Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings

Shares (Q2 2026)
1,699
Value
$631.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KRYS by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,699$631.5K<0.1%+11+0.7%AddedHolders
Q1 20261,688$436.0K<0.1%+8+0.5%AddedHolders
Q4 20251,680$414.2K<0.1%−183−9.8%ReducedHolders
Q3 20251,863$328.9K<0.1%00.0%UnchangedHolders
Q2 20251,863$256.1K<0.1%+132+7.6%AddedHolders
Q1 20251,731$312.1K<0.1%−1,506−46.5%ReducedHolders
Q4 20243,237$507.1K<0.1%00.0%UnchangedHolders
Q3 20243,237$589.2K<0.1%00.0%UnchangedHolders
Q2 20243,237$594.4K<0.1%−15−0.5%ReducedHolders
Q1 20243,252$578.6K<0.1%−794−19.6%ReducedHolders
Q4 20234,046$501.9K<0.1%−125−3.0%ReducedHolders
Q3 20234,171$483.8K<0.1%+53+1.3%AddedHolders
Q2 20234,118$483.5K<0.1%−11,987−74.4%ReducedHolders
Q1 202316,105$1.29M<0.1%−17−0.1%ReducedHolders
Q4 202216,122$1.28M0.1%−5,236−24.5%ReducedHolders
Q3 202221,358$1.49M0.1%+74+0.3%AddedHolders
Q2 202221,284$1.40M0.1%−3,281−13.4%ReducedHolders
Q1 202224,565$1.64M0.1%−9,471−27.8%ReducedHolders
Q4 202134,036$2.38M0.1%+28,582+524.1%AddedHolders
Q3 20215,454$285.0K<0.1%00.0%UnchangedHolders
Q2 20215,454$371.0K<0.1%00.0%UnchangedHolders
Q1 20215,454$420.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.